Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

The phase 1 KEYNOTE-603 study, published in Cancer Discovery, showed that the combination of mRNA-4157 and Keytruda (pembrolizumab) produced anti-tumor responses in patients with resected NSCLC (four ...

Southampton scientists working to improve survival for cancer patients have identified a key characteristic of the disease ...

New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The American Cancer Society said one in eight men will be ...

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to ...

A surprising discovery reveals that a gene previously thought to accelerate esophageal cancer actually helps protect against it initially. This pivotal study could lead to better prediction and ...

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective ...

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...

Cancer natives in 2025 will experience a year of transformation in their relationships. Saturn's transit will prompt ...

A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease. This unexpected discovery could help doctors identify which ...